v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 43,210 $ 17,256
Prepaid expenses, deposits, and other current assets 3,126 1,685
Total current assets 46,336 18,941
Other assets 1,035 837
Total assets 47,371 19,778
Current liabilities:    
Accounts payable 3,766 2,966
Accrued expenses and other current liabilities 1,565 2,325
CARES Act Paycheck Protection Program note payable 300
Senior Secured Convertible Notes - at fair value 10,060
Senior Convertible Note - at fair value 4,600
Total liabilities 5,331 20,251
Commitments and contingencies (Note 5)
Stockholders’ Equity (Deficit):    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,185,685 at June 30, 2021 and 1,228,075 shares at December 31, 2020 2,499 2,537
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 82,576,816 and 63,819,935 shares outstanding as of June 30, 2021 and December 31, 2020, respectively 83 64
Additional paid-in capital 149,694 87,570
Accumulated deficit (109,325) (88,275)
Total PAVmed Inc. Stockholders’ Equity 42,951 1,896
Noncontrolling interests (911) (2,369)
Total Stockholders’ Equity (Deficit) $ 42,040 $ (473)

Source